MVCAX
Price
$28.58
Change
-$1.68 (-5.55%)
Updated
Apr 3 closing price
Net Assets
16.94B
SMVTX
Price
$10.79
Change
-$0.83 (-7.14%)
Updated
Apr 3 closing price
Net Assets
1.53B
Ad is loading...

MVCAX vs SMVTX

Header iconMVCAX vs SMVTX Comparison
Open Charts MVCAX vs SMVTXBanner chart's image
MFS Mid Cap Value A
Price$28.58
Change-$1.68 (-5.55%)
VolumeN/A
Net Assets16.94B
Virtus Ceredex Mid-Cap Value Equity I
Price$10.79
Change-$0.83 (-7.14%)
VolumeN/A
Net Assets1.53B
MVCAX vs SMVTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVCAX vs. SMVTX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a StrongBuy and SMVTX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.9B vs. SMVTX (1.54B). SMVTX pays higher dividends than MVCAX: SMVTX (1.07) vs MVCAX (0.90). MVCAX was incepted earlier than SMVTX: MVCAX (24 years) vs SMVTX (23 years). SMVTX (1.02) and MVCAX (1.00) have similar cost to investors . SMVTX is a more actively managed with annual turnover of: 140.00 vs. MVCAX (27.00). MVCAX has a lower initial minimum investment than SMVTX: MVCAX (1000) vs SMVTX (100000). MVCAX annual gain was more profitable for investors over the last year : -4.59 vs. SMVTX (-7.59). MVCAX return over 5 years is better than : 96.65 vs. SMVTX (52.60).
MVCAXSMVTXMVCAX / SMVTX
Total Expense Ratio0.991.0297%
Annual Report Gross Expense Ratio1.001.0298%
Fund Existence24 years23 years-
Gain YTD-1.369-3.16743%
Front Load6%N/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets16.9B1.54B1,101%
Annual Yield % from dividends0.901.0784%
Returns for 1 year-4.59-7.5960%
Returns for 3 years0.73-5.08-14%
Returns for 5 years96.6552.60184%
Returns for 10 years55.23-8.43-655%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABEO4.950.27
+5.77%
Abeona Therapeutics
OCX2.92-0.03
-1.02%
Oncocyte Corp
VICI31.66-0.53
-1.65%
VICI Properties
FOUR79.29-6.53
-7.61%
Shift4 Payments
MRC10.56-1.13
-9.67%
MRC Global